An Endogenous Pain Pathway Worked Independently of Endocannabinoid Mechanisms in Rodents

A rodent study found pain-related benefits from activating an endogenous adenosine pathway independently of opioid and endocannabinoid mechanisms. Endogenous pain modulation is therefore not automatically evidence of cannabinoid-receptor involvement.

The intervention targeted adenosine signaling

Researchers increased endogenous adenosine through kinase inhibition and separately tested a selective A3-receptor agonist. Receptor blockade and knockout comparisons supported an A3-related mechanism. The study did not administer THC, and it should not be cited as a cannabis treatment experiment.

Effects depended on the pain state

The interventions alleviated persistent neuropathic pain-related measures, including non-evoked behavior, without changing the tested nociceptive thresholds in unaffected animals. An effect in an injury model can therefore coexist with a null response in a baseline test. Those observations describe different conditions rather than contradictory findings.

Preserved effect and lack of reward were bounded outcomes

The investigators reported no analgesic tolerance or inherent reward under the procedures used. These are specific preclinical observations, not proof of permanent effectiveness or universal absence of abuse risk in people. The reported independence from endocannabinoid mechanisms also does not establish that cannabinoid and adenosine biology can never interact in another setting.

Interpreting the evidence

The source provides a useful mechanistic comparison for cannabinoid research: similar pain-related outcomes can arise through different pathways. It does not establish a clinical alternative to cannabis or a human treatment recommendation.

Related reading: a lipid pathway with ineffective cannabinoid-receptor blockers.

Research reference

Little JW; Ford A; Symons-Liguori AM; et al. (2015). Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. Brain : a journal of neurology. doi:10.1093/brain/awu330. Evidence basis: study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Admission Samples in a Residual-THC Study Were Not Automatically Baseline Measurements

The first sample collected after admission to detoxification is not automatically a stable residual-THC baseline. In a study of heavy cannabis users, some participants had smoked only an hour or two before entering treatment. The investigators explicitly cautioned against treating every first-day result as a baseline concentration. Admission and last…

Spread the love

Read Article: Admission Samples in a Residual-THC Study Were Not Automatically Baseline Measurements

An Endogenous Pain Pathway Worked Independently of Endocannabinoid Mechanisms in Rodents

A rodent study found pain-related benefits from activating an endogenous adenosine pathway independently of opioid and endocannabinoid mechanisms. Endogenous pain modulation is therefore not automatically evidence of cannabinoid-receptor involvement. The intervention targeted adenosine signaling Researchers increased endogenous adenosine through kinase inhibition and separately tested a selective A3-receptor agonist. Receptor blockade…

Spread the love

Read Article: An Endogenous Pain Pathway Worked Independently of Endocannabinoid Mechanisms in Rodents

Cannabis in a Mixed-Drug Fatality Series: Hair and Blood Answer Different Exposure Questions

A Danish methadone-fatality study reported extensive mixed-drug exposure, including cannabis, and used segmental hair analysis to extend the exposure history beyond blood testing. That additional history was not proof of simultaneous intoxication from every listed substance. The two matrices supplied different information The study examined fatalities with both blood and…

Spread the love

Read Article: Cannabis in a Mixed-Drug Fatality Series: Hair and Blood Answer Different Exposure Questions

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us